Table S1: Characteristics of included pharmacogenomics studies involving intramuscular administration routes Table S2: Outcomes and results of included pharmacogenomics studies on intramuscular admini
Table S2. List of current drug indications with a significant overlap between genes significantly up- or down-regulated after drug treatment and GWAS hits. Results are filtered for adjusted p-value
Medication safety and efficacy-related pharmacogenomic research play a critical role in precision medicine. This study comprehensively analyzed the pharmacogenomic profiles of the central Han Chinese
CYP2C19 is one of the most important drug metabolizing enzymes in human body. The gene base is located in chromosome region 10q 24.2 and consists of 9 exons. CYP2C19 has many single nucleotide polymor
The Keap1/Nrf2 signaling pathway is a tractable target for the pharmacological prevention of tumorigenesis. 3H-1,2-dithiole-3-thione (D3T) and 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole